Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Licenses Molecular Dx Technology from Xceed

NEW YORK (GenomeWeb News) – Xceed Molecular announced yesterday that Gen-Probe has taken a non-exclusive license to the firm’s Flow-Thru Chip technology.
 
The Wellesley, Mass.-based company said that Gen-Probe expects to use the technology in developing next-generation multiplexed molecular diagnostics.
 
Under terms of the deal, Gen-Probe will pay up-front licensing and milestone fees to Xceed for non-exclusive access to the chip technology in certain fields. Gen-Probe also has the right to receive co-exclusive rights with Xceed in certain undisclosed sub-fields. San Diego-based Gen-Probe also will make royalty payments to Xceed based on sales and will purchase Xceed’s custom TipChips, Ziplex automated gene expression system, and other Xceed products.
 
“There are many promising applications for moderate-density arrays in clinical diagnostics and other applications, and we believe that Xceed’s technologies in combination with our own technologies will facilitate our entry into these expanding markets,” Dan kacian, executive vice president and chief scientist for Gen-Probe, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more